bc-ontologyGovernments, institutions, geography and law
Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

21 CFR Part 26, Subpart A—Specific Sector Provisions for Pharmaceutical Good Manufacturing Practices

21 CFR Part 26, Subpart A—Specific Sector Provisions for Pharmaceutical Good Manufacturing Practices, “Specific Sector Provisions for Pharmaceutical Good Manufacturing Practices”, is a CFR division of 21 CFR Part 26—Mutual recognition of pharmaceutical good manufacturing practice reports, medical device quality system audit reports, and certain medical device product evaluation reports: United States and the European Community.

https://ontology.bommaritollc.com/id/01a0f094-b4ba-778d-86dc-989054e0de2d
schema:Legislation
Download TurtleJSON-LDN-TriplesMarkdown
Cite this
21 CFR Part 26, Subpart A—Specific Sector Provisions for Pharmaceutical Good Manufacturing Practices. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-b4ba-778d-86dc-989054e0de2d

Elsewhere

Facts

adms:identifier
prov:wasDerivedFrom
schema:isPartOf
schema:legislationIdentifier
21 CFR Part 26, Subpart A
schema:legislationJurisdiction
schema:legislationType
schema:name
Specific Sector Provisions for Pharmaceutical Good Manufacturing Practicesen
skos:prefLabel
21 CFR Part 26, Subpart A—Specific Sector Provisions for Pharmaceutical Good Manufacturing Practicesen

Related

Parts (26)schema:isPartOf